Deep Blue BioTech

The good news just keeps coming. Congratulations to Tim Corcoran , Manuel Rios Krauss, Maria Lucia Burdisso, PhD and the other winners. Thanks to Blue Bio Value for all of their hard work on a fantastic programme.

After months of hard work, we’ve done it—Deep Blue BioTech has secured $800k in pre-seed funding! I sat down with Natasha Lomas from TechCrunch last week to share our journey and what's next after this milestone. Check the article here (https://lnkd.in/dcy_ti-k). Raising in today’s market was no joke—it took grit, resilience, and a shared belief in our mission to transform CO₂ into superior and sustainable chemicals. We’re proud to have the backing of investors who see the potential of what we’re building. Thanks to everyone who’s believed in us so far—it’s been an incredible journey to get to this milestone, especially to Joshua Armistead-Wood, Edward Stevenson, Paul T., Anthony Chant & Matt Jellicoe. I’m especially excited to see Tim Corcoran step into the CEO role. Tim is a visionary leader with both the drive and heart to guide us through this next phase. I couldn’t ask for a better partner to build this with. For me, moving into the role of Chair of Innovation and Business Development is a chance to focus on being strategic and intentional about how we innovate, scale, and make an impact. At Deep Blue, we’re pioneering a future where we turn CO₂ into value instead of waste. With our unique cyanobacteria platform, we’re tackling some of the biggest challenges in carbon management—and our first product, Hyaluronic Acid, is only the beginning. This is the start of something big. If we can scale our technology and unlock the full potential of CO₂ transformation, we can make a serious dent in global emissions. Here’s to the incredible team at Deep Blue BioTech and to everyone joining us on this journey—we’re just getting started. Let’s build something extraordinary. 🌍 #SyntheticBiology #Cyanobacteria #BioEconomy #Sustainability #StartupLife Sustainable Ventures SFC Capital One Planet Capital PCS International Limited

🌍 𝐀 𝐭𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐯𝐞 𝐦𝐨𝐦𝐞𝐧𝐭 𝐟𝐨𝐫 𝐃𝐞𝐞𝐩 𝐁𝐥𝐮𝐞 𝐁𝐢𝐨𝐓𝐞𝐜𝐡: We closed our $800k pre-seed funding which marks the start of a new chapter in sustainable biomanufacturing. Cyanobacteria—nature’s photosynthetic powerhouses—are at the heart of our mission to create regenerative ingredients that outperform conventional alternatives. With this funding, led by Sustainable Ventures and joined by visionary partners like SFC Capital, One Planet Capital, PCS International Limited, Carbon13, and Innovate UK, we’re scaling faster to meet the demand for sustainable solutions across beauty, personal care, and industrial chemicals. This is more than funding—it’s a step toward redefining how we make materials. By unlocking the potential of light and CO2, we’re building a production paradigm that works with nature, not against it. Here’s to innovation, sustainability, and a future shaped by cyanobacteria. #DeepBlueBioTech #RegenerativeIngredients #Biomanufacturing #CyanobacteriaRevolution #SyntheticBiology #BioEconomy Tim Corcoran Maria Lucia Burdisso, PhD Manuel Rios Krauss

🌍 Revolutionizing Green Chemistry with Cyanobacteria: Deep Blue BioTech's Vision 🌱 As the race to decarbonize intensifies, groundbreaking innovations are emerging to transform industries. Enter Deep Blue BioTech, a UK-based startup pioneering sustainable chemical production using photosynthesis-driven biomanufacturing. Founded in 2023, the company is leveraging cyanobacteria (commonly known as blue-green algae) to create cost-effective, environmentally friendly "green chemicals." Co-founder Manuel Rios Krauss emphasizes their mission: “We create that new generation of sustainable materials, new generation of green chemicals, that are environmentally conscious — but mainly they are superior in functionality.” Their first target? The beauty and cosmetics industry, with hyaluronic acid as the debut product. This approach not only removes CO2 through photosynthesis but also achieves high efficiency using a recently discovered strain of cyanobacteria with three times the growth rate and seven times the productivity of others. Backed by $800,000 in pre-seed funding, including Innovate UK grants, Deep Blue BioTech is poised to scale its modular, photobioreactor-based system for faster commercialization. With potential expansion into textiles and beyond, the startup is driving both sustainability and performance in chemical production. As the industry strives for greener solutions, initiatives like this represent a vital step forward. #Sustainability #GreenChemicals #BiotechInnovation #SyntheticBiology #ClimateAction #CosmeticsInnovation #DeepTech

🧬 Leading with Science: 𝐌𝐞𝐞𝐭 𝐎𝐮𝐫 𝐍𝐞𝐰 𝐂𝐡𝐢𝐞𝐟 𝐒𝐜𝐢𝐞𝐧𝐭𝐢𝐟𝐢𝐜 𝐎𝐟𝐟𝐢𝐜𝐞𝐫 We’re delighted to welcome Maria Lucia Burdisso, PhD, a biotechnologist, as Deep Blue BioTech's new Chief Scientific Officer! With over eight years of R&D experience spanning academia and cutting-edge biotech startups, Maria Lucia brings a wealth of expertise and leadership to our team. During her PhD in Biological Sciences and her work in startups, Maria Lucia specialized in the genetic engineering of microalgae and cyanobacteria, unlocking their potential for innovative applications. This expertise perfectly complements Deep Blue BioTech’s mission to leverage synthetic biology platforms and cyanobacteria to produce essential chemicals sustainably. Her career journey has taken her to 10 laboratories across 4 countries, equipping her with exceptional adaptability, problem-solving skills, strategic planning abilities, and a global perspective. Maria Lucia’s diverse international experiences have sharpened her interpersonal skills and collaborative approach, making her a natural fit for our dynamic team. As an accomplished assay development scientist, she has also demonstrated exceptional project management and team leadership capabilities. Her drive to make things happen, combined with her passion for sustainable solutions, will be pivotal as we continue to push the boundaries of innovation. We’re thrilled to welcome Maria Lucia to Deep Blue BioTech and can’t wait to see what we’ll achieve together!  Join us in welcoming Maria Lucia to the team! #Biotechnology #Cyanobacteria #SyntheticBiology #Innovation #BioEconomy #NewHire

🌟 We’re honored to share that Deep Blue BioTech has been named a Deep Tech Pioneer by Hello Tomorrow! 🌟 Out of thousands of applications, our Cyanobacteria biotechnology platform for biomanufacturing high-value green chemicals stood out to their experts, and we couldn’t be more excited. Join us at the 10th Hello Tomorrow Global Summit this March 2025—a powerhouse gathering for deep tech trailblazers, investors, and innovators pushing solutions from the lab to market. This is where connections turn into collaborations. Don’t miss it! 🚀 👉https://lnkd.in/g8keznYm #Cyanobacteria #SyntheticBiology #GreenChemicals #BioEconomy

🚀 Announcing Cohort 7 of our Europe CDR Startup #Accelerator Program 🚀 We are thrilled to kick-off the latest cohort of remove's Foundations program and onboard a new set of promising Europe-based CDR #startups! These teams are raising the bar every cohort. The quality of applications we received over the last couple of months is a testament to the fact that this industry is maturing and we are excited to be supporting the key actors driving #carbon removal forward. After careful consideration in a competitive process, our jury of experts selected 20 teams to join us on this journey. 👏 Congratulations to: SuperDAC (Silvia Pugliese), Bloomineral, Residual (Ted Christie-Miller & Laura Fritsch), Porelio, Artio, X-SAF (Benjamin Schulz), Kumo, UAP | Atmosphere Engineering, Bluelotus.solutions, biodiversityX, neo-fossil, Atmosfuture Limited, OXO Earth, Deep Blue BioTech, Bigfoot, Nina.Energy, AEROC, Pyrogen, BCHAR on their selection! We are looking forward to working with this new and exciting group of startups, supporting them with training, 1-on-1 coaching, connections to experts, buyers, investors, other #CDR ecosystem stakeholders, non-dilutive #funding and more. remove is the premier accelerator program focused solely on CDR in Europe and India and we are supported by incredible founding partners: The Grantham Foundation for the Protection of the Environment, Carbon Removal Partners, and The DOEN Foundation.

🚀 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀! 𝗗𝗲𝗲𝗽 𝗕𝗹𝘂𝗲 𝗕𝗶𝗼𝗧𝗲𝗰𝗵 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝘀𝗲𝗹𝗲𝗰𝘁𝗲𝗱 𝗳𝗼𝗿 𝗖𝗼𝗵𝗼𝗿𝘁 𝟳 𝗼𝗳 𝘁𝗵𝗲 remove 𝗖𝗗𝗥 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗼𝗿 𝗶𝗻 𝗘𝘂𝗿𝗼𝗽𝗲! We’re thrilled to be part of this groundbreaking program, where we’ll collaborate with top experts in the Carbon Dioxide Removal (CDR) field to amplify the climate impact of our innovative technology. Thanks to the support of The Grantham Foundation for the Protection of the Environment, Carbon Removal Partners and The DOEN Foundation in making this possible. At Deep Blue BioTech, our mission is clear: transforming CO2 into superior high-value green chemicals. By leveraging our unique platform, powered by #SyntheticBiology and AI, we unlock the extraordinary potential of cyanobacteria—the fastest-growing photosynthetic organism on the planet. We’re eager to bring our #bioeconomy insights to this cohort and drive forward impactful partnerships that elevate our contribution to the global CDR movement. Together, we can reshape the future of sustainable innovation! We couldn’t be more impressed by the quality of our Cohort 7 fellows, we look forward to learning with them and building a stronger ecosystem: SuperDAC (Silvia Pugliese), Bloomineral, Residual (Ted Christie-Miller & Laura Fritsch), Porelio, Artio, X-SAF (Benjamin Schulz), UAP | Atmosphere Engineering, Bluelotus.solutions, biodiversityX, neo-fossil, Atmosfuture Limited, OXO Earth, Bigfoot, Nina.Energy, AEROC, Kumo, B3ET, Pyrogen, BCHAR Stay engaged for more exciting news! #CDR #GreenChemicals #Biotechnology

This week I attended The Drop in Malmö for the first time. I found it to be a truly one-of-a-kind event, and everything I heard about it before probably didn’t do it justice. Kudos to Hampus Jakobsson and Joel Larsson for this amazing couple of days, you created something unique indeed! I particularly engaged with a topic very close to my heart: how we can finally move into the acceleration phase of the #BioEconomy. I attended a brilliant session by Max Mundt & Christian Gonzalez, PhD on this. Max's post this morning provided an excellent perspective on the differences between pioneering bio𝘱𝘳𝘰𝘥𝘶𝘤𝘵𝘴 and bio𝘱𝘳𝘰𝘤𝘦𝘴𝘴𝘦𝘴 (https://lnkd.in/dXBBaHkZ), complementing the discussions from the session. 💡 Here are my key takeaways: 🥇 𝗧𝗵𝗲 𝗶𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗻𝗲𝗲𝗱𝘀 𝗮 𝘀𝘂𝗰𝗰𝗲𝘀𝘀 𝘀𝘁𝗼𝗿𝘆—a bioeconomy poster child—that makes the benefits and potential clear to everyone. This, for me, is where the tipping point begins. 📉 𝗔𝗰𝗵𝗶𝗲𝘃𝗶𝗻𝗴 𝗰𝗼𝘀𝘁-𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲𝗻𝗲𝘀𝘀 𝘄𝗶𝗹𝗹 𝗿𝗲𝗾𝘂𝗶𝗿𝗲 𝘀𝘆𝘀𝘁𝗲𝗺𝗶𝗰 𝗰𝗵𝗮𝗻𝗴𝗲. It won’t be solved by one startup alone, but rather through the alignment of many interconnected pieces. An interdisciplinary mindset and collaboration at the core of this new generation of startups will be essential. 🎭 𝗧𝗵𝗲 𝗱𝗶𝗰𝗵𝗼𝘁𝗼𝗺𝘆 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝗹𝗼𝘄-𝘃𝗮𝗹𝘂𝗲/𝗵𝗶𝗴𝗵-𝘃𝗼𝗹𝘂𝗺𝗲 𝗮𝗻𝗱 𝗵𝗶𝗴𝗵-𝘃𝗮𝗹𝘂𝗲/𝗹𝗼𝘄-𝘃𝗼𝗹𝘂𝗺𝗲 𝗶𝘀 𝗻𝗼𝘁 𝘁𝗵𝗲 𝗿𝗶𝗴𝗵𝘁 𝗳𝗿𝗮𝗺𝗶𝗻𝗴. There are more parameters to consider, and a continuum exists where industries like Beauty & Personal Care can move from kilos to tons. Partnering with the right industry will be key to this journey. Looking at you Rushad Nanavatty. All in all, the event had incredible content, people, and conversations. One keynote title and one session particularly stood out for me: Chido Govera led a beautiful session on her foundation,The Future of Hope Foundation. I love what they’re doing to support and mentor vulnerable members of society through entrepreneurship. When I left, I couldn’t stop thinking about the phrase 𝘛𝘩𝘦 𝘍𝘶𝘵𝘶𝘳𝘦 𝘰𝘧 𝘏𝘰𝘱𝘦 itself—about our role in creating a vision of the future, one where we all can project and see ourselves thriving. At the end of the day, all this discussion about tools, science, technology and frameworks should not overshadow the "𝘸𝘩𝘺" behind our efforts. #TheDrop #BioEconomy

🌟 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀 𝗳𝗿𝗼𝗺 𝗗𝗲𝗲𝗽 𝗕𝗹𝘂𝗲 𝗕𝗶𝗼𝗧𝗲𝗰𝗵!! 🌟 We are thrilled to announce that Deep Blue BioTech has secured a place in the Science Entrepreneur Club Innovation Program. This opportunity is a crucial step in our journey to create the next generation of #GreenChemicals by pioneering a Cyanobacterial biomanufacturing platform. Being part of this program will allow us to connect with leading innovators, gain access to valuable resources, and accelerate the impact of our technology. We're excited to grow with the support of this incredible community as we continue to journey to strengthen the #BioEconomy. Stay tuned for more updates! #InnovatorsClub #Innovation #Sustainability #DeepBlueBioTech #ScienceEntrepreneursClub